NDC 60505-4858-03 - Tofacitinib

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
60505-4858
Requested NDC
60505-4858-03
Package NDCs from labels
60505-4858-3, 60505-4858-03
Manufacturer
Apotex Corp.
Effective date
2026-10-08
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Tofacitinib - Apotex Corp.Apotex Corp.2026-10-08HUMAN PRESCRIPTION DRUG LABEL
Tofacitinib - AvKAREAvKARE2026-06-24HUMAN PRESCRIPTION DRUG LABEL

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 32 · 635 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TofacitinibTOFACITINIBXLCare Pharmaceuticals Inc10403307-e2f9-44d1-bc72-552fdba299d12026-11-02Boxed warning, Warnings, Adverse reactionsExact identifier
unii: O1FF4DIV0D
MannitolMANNITOLHenry Schein, Inc.e2444db1-9dfe-451f-a33c-9b00786464d22026-11-02Warnings, Adverse reactionsExact identifier
unii: 3OWL53L36A
TofacitinibTOFACITINIBMacleods Pharmaceuticals Limited9b654f0d-7705-4880-9e9d-ad3a51e56b562026-10-22Boxed warning, Warnings, Adverse reactionsExact identifier
unii: O1FF4DIV0D
TOFACITINIB CITRATETOFACITINIB CITRATEStellon Biotech Inc.89eb2ffc-02d9-4b46-b480-e9b10af330272026-10-16Boxed warning, Warnings, Adverse reactionsExact identifier
unii: O1FF4DIV0D
TOFACITINIBTOFACITINIBSun Pharmaceutical Industries, Inc.a764a133-b870-4514-bbee-24d43f8cb7fd2026-10-16Boxed warning, Warnings, Adverse reactionsExact identifier
unii: O1FF4DIV0D
TOFACITINIB CITRATETOFACITINIB CITRATECONCORD BIOTECH LIMITED6c33e5b4-4843-4a80-a4f8-435bfceddc2a2026-10-16Boxed warning, Warnings, Adverse reactionsExact identifier
unii: O1FF4DIV0D
TofacitinibTOFACITINIBSaptalis Pharmaceuticals, LLC.c6c033ff-bce0-4d1c-a182-3b13191686e12026-10-15Boxed warning, Warnings, Adverse reactionsExact identifier
unii: O1FF4DIV0D
Artificial TearsGLYCERINPreferred Pharmaceuticals Inc.dd646c72-8f47-43c6-a734-db0dcc8cd4d12026-10-14WarningsExact identifier
unii: 3NXW29V3WO
TOFACITINIB CITRATETOFACITINIB CITRATEGolden State Medical Supply, Inc.5dd43533-dadc-2acb-e063-6394a90a413f2026-10-14Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1741046
unii: O1FF4DIV0D
tofacitinibTOFACITINIBZydus Pharmaceuticals USA Inc.179ffbb2-bedc-40e6-b77b-33d4f78321722026-10-09Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1741046
unii: O1FF4DIV0D
TofacitinibTOFACITINIBApotex Corp.dd62a2b8-300b-d92b-7b27-a30eaa68fdd32026-10-08Boxed warning, Warnings, Adverse reactionsExact identifier
application number: ANDA220458
ndc (package): 60505-4858-3
ndc (product): 60505-4858
ndc11 (package): 60505485803
rxcui: 1741046
spl id: cca6e2e3-13e4-2ab5-5750-4a62f654355e
spl set id: dd62a2b8-300b-d92b-7b27-a30eaa68fdd3
unii: O1FF4DIV0D
Tofacitinib XRTOFACITINIBBiocon Pharma Incf0160e3d-63ea-75fb-4b88-fe3d6a6ce0302026-10-07Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1741046
unii: O1FF4DIV0D
XELJANZTOFACITINIBU.S. Pharmaceuticals68e3d6b2-7838-4d2d-a417-09d919b43e132026-10-06Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1741046
unii: O1FF4DIV0D
TofacitinibTOFACITINIBAjanta Pharma USA Inc.024bb9f2-8c26-4d9d-a33b-eb3c0a7c59ed2026-10-05Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1741046
unii: O1FF4DIV0D
tofacitinibTOFACITINIBZydus Pharmaceuticals USA Inc.21a89264-8047-40ac-8b10-fa64610725092026-10-05Boxed warning, Warnings, Adverse reactionsExact identifier
unii: O1FF4DIV0D
TOFACITINIBTOFACITINIBBryant Ranch Prepack89211a4d-befb-40f1-8792-aa599fdd794c2026-10-02Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1741046
unii: O1FF4DIV0D
TOFACITINIBTOFACITINIBMicro Labs Limitedffa6819b-23a4-478b-8fb7-cc90e8142fc52026-09-25Boxed warning, Warnings, Adverse reactionsExact identifier
unii: O1FF4DIV0D
tofacitinib solutionTOFACITINIBHikma Pharmaceuticals USA Inc.d9cf18a9-e825-49ac-b080-68957c0e79ae2026-09-24Boxed warning, Warnings, Adverse reactionsExact identifier
unii: O1FF4DIV0D
Lymph Tonic IIECHINACEA (ANGUSTIFOLIA), COLLINSONIA CANADENSIS, PHYTOLACCA DECANDRA, KALI IODATUM, PINUS SYLVESTRIS, PIX LIQUIDA, FERRUM PHOSPHORICUM, AESCULUS HIPPOCASTANUM, BARYTA CARBONICA, BERBERIS VULGARIS, CALCAREA CARBONICA, CALCAREA PHOSPHORICA, CAUSTICUM, HEPAR SULPHURIS CALCAREUM, KREOSOTUM, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, NATRUM MURIATICUM, NITRICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), SILICEA, STELLARIA MEDIA, SULPHUR, TEREBINTHINA, THUJA OCCIDENTALIS, BUFO RANABioActive Nutritional, Inc.0e3265b0-b210-4a4c-80d2-8a9712981d4e2026-09-17WarningsExact identifier
unii: ETJ7Z6XBU4
Psoriasis ControlCENTELLA ASIATICA, SODIUM CHLORIDE, AND SILICON DIOXIDEForces of Nature2db33771-0bb9-49f8-84fa-dddc28e4ba262026-09-04WarningsExact identifier
unii: ETJ7Z6XBU4

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.